Cite
HARVARD Citation
Liu, R. et al. (2019). Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis. Annals of the rheumatic diseases. 78 (11), pp. 1524-1535. [Online].